Optimer Pharmaceuticals Names CEO

San Diego-based Optimer Pharmaceuticals, a biopharmaceuticals firm focused on antibiotics, said today that it has appointed Pedro Lichtinger as its new President and CEO. Lichtinger replaces Michael N. Chang, co-founder of the firm, who will become Chairman of the firm's board. Lichtinger joins from Pfizer, where he was most recently President of Pfizer's Global Primary Care Business Unit. Lichtinger had been at Pfizer since 1995.